NCT03516110 2026-01-23
PRISME
Ipsen
Completed
Clinical Trials
26 trialsNCT05017662 2025-09-04
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
Ariceum Therapeutics GmbH
Phase NA Completed
NCT02312960 2025-03-25
Radium-223 Dichloride Long-term Follow-up Program
Bayer
Phase 4 Completed
NCT04994795 2024-11-21
DEEP-Lung-IV
Sophia Genetics SAS
Active not recruiting
NCT03259230 2024-09-19
Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis
Swedish Orphan Biovitrum
Completed
NCT04253015 2024-02-07
A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta
RECORDATI GROUP
Recruiting
NCT05437679 2023-09-05
CHARTER
Angle plc
Terminated
NCT03419572 2022-08-15
CASSIOPE
Ipsen
Completed
NCT04590716 2021-07-29
Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares
doc.ai inc
Completed
NCT03562091 2020-08-28
OPERA
Ipsen
Completed
NCT03112694 2020-06-02
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
Ipsen
Completed
NCT03220087 2018-12-21
RECOSY
Ipsen
Completed
NCT01290393 2018-07-26
Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada
GlaxoSmithKline
Terminated
NCT01101542 2018-07-23
Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females
GlaxoSmithKline
Completed
NCT02300831 2017-07-14
LUMINIST
AstraZeneca
Completed
NCT02262273 2017-03-01
OSCA
AstraZeneca
Completed
NCT01953822 2016-12-26
Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom
GlaxoSmithKline
Completed
NCT01498627 2015-04-06
PGRx
GlaxoSmithKline
Completed
NCT01153906 2014-12-02
Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination
GlaxoSmithKline
Completed
NCT01772225 2014-03-31
LuCaBIS
GlaxoSmithKline
Completed
NCT01905462 2013-09-30
Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK
GlaxoSmithKline
Completed
NCT01551537 2013-09-09
Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka
GlaxoSmithKline
Withdrawn
NCT01207999 2012-11-22
Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
GlaxoSmithKline
Completed
NCT01213459 2012-11-22
Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia
GlaxoSmithKline
Completed
NCT01328028 2012-08-27
Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand
GlaxoSmithKline
Completed
NCT01221987 2012-04-30
Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer
GlaxoSmithKline
Completed